- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03721913
Participation-based Intervention on Community Participation and Parent Empowerment for Children With ASD (PBI-ASD)
Efficacy of Participation-based Intervention on Community Participation and Parent Empowerment for Children With Autism Spectrum Disorder
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Children with Autism Spectrum Disorder (ASD) have social interaction and communication disorders, restricted interests and repetitive behaviors, which may further restrict daily activities and participation. Participation of children with ASD often are more restricted in the community than at home and school, due to problems such as environmental barriers and resources inadequacy. Research showed that school-age children with ASD participated less in social, leisure and sports activities than children with typical development, thus may result in loneness or social isolation and impact on long-term physical and psychological health.
Community participation of children with ASD is affected by child (including body function and personal factors), family and environmental factors. This study proposes an innovative Participation-based intervention based on the principles of self-determined, family-centered, strength-based, and solution-focused approaches. This intervention targets on promoting children's community participation, and forms solution strategies from analyzing the strength and needs of child, family, and environment. The aim of this study is to investigate the efficacy of participation-based intervention on community participation and family empowerment for children with ASD 6-10 years of age.
This study is proposed as a 2-year project that will use a stratified randomized controlled trial design to examine the efficacy of participation-based intervention (experimental group) in comparison to no additional intervention (control group). The study period includes 12-week intervention phase and 12-week follow-up phase, and 3 outcome measures: pre-test, post-test, and follow-up. The primary outcomes are children's community participation, the secondary outcomes are parental empowerment, family quality of life, and satisfaction with partnerships. This study will have great impact on promoting collaboration among child, family and therapists, and supporting full inclusion in society of children with ASD and their families.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Taoyuan, Taiwán, 333
- Chang Gung University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Children are elementary school students between the ages of 6 and 10
- Diagnosed with Autism spectrum disorder by DSM-V with a medical certificate, and reached the cut-off score (7 points) of Autism Behavior Checklist-Taiwan version(ABC-T).
- Children have an IQ of at least 70 (as measured by Wechsler Intelligence Scale for Children).
- Parents agree to participate in this study and sign the consent form.
- Children over 7 years should provide written consent form.
Exclusion Criteria:
- Children with unstable physical conditions within 3 months, such as cancer, having surgery, infection, or other active medical conditions.
- Children have known genetic conditions (e.g., Down syndrome, Fragile X Syndrome).
- Children have diagnosis associated with physical disability (e.g. cerebral palsy, congenital malformations, or musculoskeletal disorders)
- Children have significant sensory impairments such as visual or hearing impairments.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Intervention group
The participation-based intervention is a goal-orientated, family-centered, and self-determined approach that emphasize on solution strategies based on child and family-selected goals.
Intervention strategies will be formed by analyzing the strength and needs of child, family, and environment, and implemented by collaboration between family and interventionists.
|
The participation-based intervention is a goal-orientated, family-centered, and self-determined approach that emphasize on solution strategies based on child and family-selected goals.
Intervention strategies will be formed by analyzing the strength and needs of child, family, and environment, and implemented by collaboration between family and interventionists.
|
|
Sin intervención: Control group
The control group will not receive the intervention during the study.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in the Canadian Occupational Performance Measure (COPM) performance and satisfaction scores
Periodo de tiempo: From baseline to post-intervention at 12 weeks and follow-up at 24 weeks
|
The COPM is a measure for identifying children's participation problems and prioritizing the goals.
The parents will be asked to use a 10-point rating scales (1-10: higher scores indicating better performance and higher satisfaction) to rate their perception of performance and satisfaction of the goals.
|
From baseline to post-intervention at 12 weeks and follow-up at 24 weeks
|
|
Change in the Goal Attainment Scaling (GAS) scores
Periodo de tiempo: From baseline to post-intervention at 12 weeks and follow-up at 24 weeks
|
The GAS is a measure for evaluating the goal attainment.
It is a five level scale ranged from -2 to +2 where -2 represented the level of performance before intervention, 0 the expected level of attainment after intervention and +2 represented a level of attainment that exceeded expectations.
|
From baseline to post-intervention at 12 weeks and follow-up at 24 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Parent Empowerment and Efficacy Measure (PEEM)
Periodo de tiempo: Baseline, post-intervention at 12 weeks and follow-up at 24 weeks
|
The PEEM is a 20-item questionnaire designed to measure parent functioning.
The parents will be asked to use a 10-point scale to indicate how well each statement captures the way they feel about themselves in relation to their role as parent.
A rating of 1 is used to indicate that the statement is a poor match for the way they feel and sounds nothing like them.
A rating of 10 indicates that the statement is a perfect match and describes exactly how they feel.
The total possible score ranges from 20 to 200.
|
Baseline, post-intervention at 12 weeks and follow-up at 24 weeks
|
|
Family Quality of Life (FaQoL)
Periodo de tiempo: Baseline, post-intervention at 12 weeks and follow-up at 24 weeks
|
The FaQoL(McWilliam, 2011) is a 40-item questionnaire rate on a 5-point scale (1-poor to 5-excellent) for parents to rate their perception of satisfaction.
|
Baseline, post-intervention at 12 weeks and follow-up at 24 weeks
|
|
Chinese version of Family-Professional Partnership Scale (FPPS-P-C)
Periodo de tiempo: post-intervention at 12 weeks and follow-up at 24 weeks
|
(only for the intervention groups) The FPPS-P-C is a 18-item scale for assessing parents' perceptions of the importance of and their satisfaction with family-professional partnerships.
The parents will be asked to indicate how important each item was for their partnership with a professional serving their child using a 5-point scale, ranging from 1 (not at all important) to 5 (very important).
|
post-intervention at 12 weeks and follow-up at 24 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Lin-Ju Kang, PhD, Chang Gung University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 201800429A3
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .